SYNCOM FORMULATION (INDIA)
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Syncom Formulation (India) along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-1.77₹ -0.26
As on Dec 18, 2025, 4:01 PM IST
Syncom Formulation (India) Price Performance
Today's LowToday's High
₹14.33₹14.64
₹14.39
52 Weeks' Low52 Weeks' High
₹14.10₹23.46
₹14.39
Open Price
₹14.51
Prev. Close
₹14.65
Volume
1,63,661
Over the last 5 years, the share price of Syncom Formulation (India) has gained 32.01% CAGR. Over the past year, the corresponding return has been -31.70%.
Syncom Formulation (India)’s current P/E of 21.46x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Syncom Formulation (India) Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Syncom Formulation (India) | -3.55 | -10.62 | -19.61 | -22.97 | -31.87 | 22.28 | 32.01 |
| Sun Pharmaceutical Industries | -2.69 | -2.14 | 5.43 | 5.99 | -4.24 | 20.90 | 24.86 |
| Divi's Laboratories | -0.60 | -1.01 | 3.06 | -1.62 | 9.73 | 24.04 | 10.77 |
| Torrent Pharmaceuticals | -0.63 | 0.95 | 3.69 | 18.86 | 8.60 | 33.11 | 22.12 |
| Cipla | -1.19 | -1.79 | -4.85 | 1.08 | -0.45 | 10.99 | 13.56 |
| Dr. Reddy's Laboratories | 0 | 2.36 | -3.26 | -3.53 | -3.50 | 13.31 | 4.11 |
| Lupin | 0.23 | 4.63 | 3.05 | 9.65 | -2.00 | 42.74 | 16.86 |
| Zydus Lifesciences | -2.05 | -2.19 | -12.25 | -4.20 | -7.68 | 30.52 | 13.82 |
| Mankind Pharma | -2.04 | -3.97 | -19.77 | -8.08 | -26.11 | 14.45 | 8.44 |
| Aurobindo Pharma | 1.45 | -1.78 | 8.28 | 11.79 | -3.54 | 40.38 | 6.45 |
| Alkem Laboratories | -2.21 | -3.95 | -0.50 | 15.26 | 0.17 | 22.43 | 13.24 |
| Abbott India | -0.32 | -5.78 | -8.02 | -10.13 | -4.07 | 10.11 | 11.52 |
| Glenmark Pharmaceuticals | -0.94 | 6.26 | -6.20 | 19.24 | 26.97 | 67.47 | 30.53 |
| Laurus Labs | 0.10 | 2.89 | 9.03 | 57.30 | 77.39 | 37.85 | 23.47 |
| Biocon | 1.42 | -4.32 | 6.20 | 12.49 | 11.93 | 14.24 | -3.62 |
| GlaxoSmithKline Pharmaceuticals | -2.24 | 0.84 | -7.24 | -20.49 | 9.22 | 24.02 | 9.53 |
| Anthem Biosciences | -3.45 | 4.98 | -20.29 | -7.58 | -7.58 | -2.59 | -1.56 |
| Ipca Laboratories | -3.32 | -1.91 | -0.79 | 4.23 | -10.99 | 18.41 | 4.91 |
| Ajanta Pharma | -2.08 | 3.53 | 2.33 | 2.39 | -9.50 | 30.31 | 18.84 |
| J B Chemicals & Pharmaceuticals | -0.62 | 2.06 | 4.35 | 7.04 | -6.48 | 20.22 | 27.44 |
Over the last one year, Syncom Formulation (India) has declined 31.87% compared to peers like Sun Pharmaceutical Industries (-4.24%), Divi's Laboratories (9.73%), Torrent Pharmaceuticals (8.60%). From a 5 year perspective, Syncom Formulation (India) has outperformed peers relative to Sun Pharmaceutical Industries (24.86%) and Divi's Laboratories (10.77%).
Syncom Formulation (India) Financials
Syncom Formulation (India) Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 14.87 | 14.7 |
| 10 | 14.98 | 14.9 |
| 20 | 15.31 | 15.21 |
| 50 | 16.03 | 15.87 |
| 100 | 16.75 | 16.56 |
| 200 | 17.46 | 17.14 |
Syncom Formulation (India) Share Holding Pattern
In the latest quarter, Syncom Formulation (India) remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding fell to 0.10%, and public shareholding moved up to 49.33% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Syncom Formulation (India) Corporate Actions
Date Time | Announcement |
|---|---|
| Nov 22, 2025, 9:46 PM IST | Syncom Formul. - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Read With Master SEBI Circular SEBI/HO/CFD/P |
| Nov 12, 2025, 10:52 PM IST | Syncom Formul. - Regulation 33(3) Of SEBI (LODR) Regulations, 2015 - Submission Of Standalone & Consolidated Unaudited Financ |
| Nov 12, 2025, 10:44 PM IST | Syncom Formul. - Board Meeting Outcome for Regulation 33(3) Of SEBI (LODR) Regulations, 2015 Submission Of Standalone & Conso |
| Nov 07, 2025, 11:12 PM IST | Syncom Formul. - Board Meeting Intimation for Board Meeting Intimation |
| Oct 16, 2025, 11:49 PM IST | Syncom Formul. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
About Syncom Formulation (India)
Syncom Formulation (India) Ltd. is a Public Limited Listed company incorporated on 21/06/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1988PLC047759 and registration number is 047759. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 462.85 Cr. and Equity Capital is Rs. 94.00 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address7, Niraj Industrial Estate, Off Mahakali Caves Road, Mumbai Maharashtra 400093
- Contact
Management
- Mr. Ankit Kedarmal BankdaExecutive Chairman & Whole-time Director
- Mr. Vijay Shankarlal BankdaManaging Director
- Mr. Kedarmal Shankarlal BankdaWhole Time Director
- Mrs. Ruchi JindalIndependent Woman Director
- Mr. Ritesh Kumar LunkadIndependent Director
- Mr. Ankit JainIndependent Director
FAQs on Syncom Formulation (India) Share Price
What is the share price of Syncom Formulation (India)?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Syncom Formulation (India) is ₹14.39 as on Dec 18, 2025.
What kind of stock is Syncom Formulation (India)?
The Syncom Formulation (India) is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Syncom Formulation (India)?
The market cap of Syncom Formulation (India) is ₹1,352.66 Cr as on Dec 18, 2025.
What are today's High and Low prices of Syncom Formulation (India)?
Today’s highest and lowest price of Syncom Formulation (India) are ₹14.64 and ₹14.33.
What are the 52 Week High and 52 Week Low of Syncom Formulation (India)?
The 52-week high/low is the highest and lowest price at which Syncom Formulation (India) stock has traded in the past 52-week or nearly a year. The 52-week high of Syncom Formulation (India) is ₹23.46 and 52-week low of Syncom Formulation (India) is ₹14.10 as on Dec 18, 2025.
How has the Syncom Formulation (India) performed historically in terms of returns?
The Syncom Formulation (India) has shown returns of -1.77% over the past day, -12.15% for the past month, -20.37% over 3 months, -31.7% over 1 year, 22.28% across 3 years, and 32.01% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Syncom Formulation (India)?
P/E ratio of and PB ratio of Syncom Formulation (India) are 21.46 and 3.95 on Dec 18, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse